By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Transfer today said that it has acquired Global Stem, a maker of tools and reagents used in stem cell research, for an undisclosed sum.

Gaithersburg, Md.-based Molecular Transfer sells transfection and transformation reagents used in the pharmaceutical, biotech, and academic research markets. The firm said that the all-cash acquisition will expand its capabilities into the stem cell and neuroscience research markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.